Balance Sheet T&D Holdings, Inc.

Equities

8795

JP3539220008

Life & Health Insurance

Market Closed - Japan Exchange Other stock markets 12:00:00 14/05/2026 pm IST			5-day change	1st Jan Change
4,002.00 ^JPY	+0.38%		+5.82%	+10.71%

07/04	T&D Holdings, Inc. - Special Call
17/03	T&D Holdings, Inc. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2026	CI

f522f702a167ca14f61cf4.dbRSSx3Yfk6BI19NeROI-IRx4CyRWWWU9-lqr83eZcE.B80CJ06pHQ_jV2wfAEvdk9FCslXpPDOknqEw_b7vVKMM-RsgK7MkNPBxZw

Published financial data: T&D HOLDINGS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	1,78300Cr	96TCr	1,27500Cr	1,86400Cr	1,39600Cr
Total Interest And Dividend Income	28TCr	31TCr	29TCr	30TCr	33TCr
Gain (Loss) on Sale of Investments, Total (Rev)	13TCr	13TCr	14TCr	24TCr	12TCr
Other Revenues, Total	18TCr	36TCr	54TCr	9.14TCr	66TCr
Total Revenues	2,37100Cr	1,74900Cr	2,24000Cr	2,49300Cr	2,51000Cr
Policy Benefits	1,81800Cr	1,38000Cr	1,67000Cr	1,82600Cr	1,81000Cr
Depreciation & Amortization - (IS) - (Collected)	653Cr	587.1Cr	575Cr	612.7Cr	649.5Cr
Selling General & Admin Expenses, Total	21TCr	23TCr	25TCr	25TCr	27TCr
Provision for Bad Debts	163.4Cr	9.9Cr	-	446.8Cr	-
Provision For Loan Losses - (Ins. / REIT / Utility Templates)	-50L	-20L	-20L	-	-
Other Operating Expenses	6.8TCr	6.96TCr	7.76TCr	7.8TCr	8.1TCr
Total Operating Expenses	2,10800Cr	1,68400Cr	2,00400Cr	2,16500Cr	2,16300Cr
Operating Income	26TCr	6.41TCr	24TCr	33TCr	35TCr
Interest Expense, Total	-155.3Cr	-169Cr	-172.3Cr	-143.4Cr	-240.3Cr
Income (Loss) on Equity Invest.	-	-	-22TCr	-239.7Cr	-120.2Cr
Currency Exchange Gains (Loss)	2.55TCr	2.82TCr	2.96TCr	6.75TCr	929Cr
Other Non Operating Income (Expenses)	-4.43TCr	-3.06TCr	-8.52TCr	-15TCr	-7.44TCr
EBT, Excl. Unusual Items	24TCr	5.99TCr	-3.97TCr	24TCr	28TCr
Gain (Loss) on Sale of Investments	-3.89TCr	-2.72TCr	-5.68TCr	-10TCr	-11TCr
Gain (Loss) on Sale of Assets	36Cr	-119.1Cr	11Cr	917Cr	309.2Cr
Asset Writedown	-291.5Cr	-3.1Cr	-8.7Cr	-173Cr	-158Cr
Other Unusual Items	-1TCr	-859.4Cr	-747Cr	-711.9Cr	-549.5Cr
EBT, Incl. Unusual Items	19TCr	2.29TCr	-10TCr	14TCr	17TCr
Income Tax Expense	2.79TCr	851Cr	2.78TCr	3.5TCr	4.13TCr
Earnings From Continuing Operations	16TCr	1.44TCr	-13TCr	10TCr	13TCr
Net Income to Company	16TCr	1.44TCr	-13TCr	10TCr	13TCr
Minority Interest	-89Cr	-24Cr	-38Cr	-126.4Cr	-99Cr
Net Income - (IS)	16TCr	1.42TCr	-13TCr	9.88TCr	13TCr
Net Income to Common Incl Extra Items	16TCr	1.42TCr	-13TCr	9.88TCr	13TCr
Net Income to Common Excl. Extra Items	16TCr	1.42TCr	-13TCr	9.88TCr	13TCr
Per Share Items
Net EPS - Basic	271.55	24.39	-237.31	183.13	241.72
Basic EPS - Continuing Operations	271.55	24.39	-237.31	183.13	241.72
Basic Weighted Average Shares Outstanding	60Cr	58Cr	56Cr	54Cr	52Cr
Net EPS - Diluted	271.26	24.36	-237.31	183.01	241.6
Diluted EPS - Continuing Operations	271.26	24.36	-237.31	183.01	241.6
Diluted Weighted Average Shares Outstanding	60Cr	58Cr	56Cr	54Cr	52Cr
Normalized Basic EPS	252.15	63.99	-45.21	275.3	330.25
Normalized Diluted EPS	251.88	63.93	-45.21	275.13	330.09
Dividend Per Share	46	56	62	70	80
Payout Ratio	16.27	216.18	-25.08	36.27	31.18
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	28TCr	8.43TCr	26TCr	35TCr	37TCr
EBITA	26TCr	6.41TCr	24TCr	33TCr	35TCr
EBIT	26TCr	6.41TCr	24TCr	33TCr	35TCr
Effective Tax Rate - (Ratio)	14.6	37.12	-26.74	25.94	24.48
Normalized Net Income	15TCr	3.72TCr	-2.52TCr	15TCr	17TCr
Non-Cash Pension Expense	-394.9Cr	-379.5Cr	-38Cr	-1.23TCr	-33Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Investment In Debt Securities	6,93000Cr	6,92700Cr	6,90900Cr	7,16300Cr	7,49300Cr
Policy Loans	11TCr	10TCr	10TCr	10TCr	10TCr
Total Other Investments	6,10300Cr	6,02100Cr	4,87500Cr	5,11800Cr	4,71900Cr
Total investments	13,13900Cr	13,04800Cr	11,88500Cr	12,38400Cr	12,31600Cr
Cash And Equivalents	1,02000Cr	89TCr	1,14100Cr	1,13800Cr	78TCr
Reinsurance Recoverable - (IS)	2.1TCr	3.43TCr	4.45TCr	7.89TCr	6.06TCr
Other Receivables - (Insurance Template)	1,85100Cr	1,76700Cr	1,81700Cr	1,80700Cr	1,73100Cr
Net Property Plant And Equipment	38TCr	37TCr	38TCr	38TCr	37TCr
Other Intangibles, Total	3.3TCr	3.51TCr	3.44TCr	4.34TCr	5.51TCr
Restricted Cash	1,13900Cr	1,32500Cr	1,21700Cr	1,15600Cr	1,11500Cr
Deferred Tax Assets Long-Term (Collected)	29Cr	50Cr	7.13TCr	26Cr	30Cr
Other Long-Term Assets, Total	30TCr	34TCr	18TCr	22TCr	19TCr
Total Assets	17,87700Cr	17,81300Cr	16,77400Cr	17,20700Cr	16,61900Cr
Liabilities
Accrued Expenses, Total	302.2Cr	198.1Cr	265.7Cr	185.3Cr	156.4Cr
Insurance And Annuity Liabilities	14,69500Cr	14,43300Cr	13,98000Cr	14,21700Cr	13,63700Cr
Unpaid Claims	7.08TCr	7.27TCr	7.56TCr	8.46TCr	8.42TCr
Reinsurance Payable - (BS)	1.21TCr	1.39TCr	2.76TCr	2.96TCr	4.22TCr
Current Portion of Long-Term Debt	962.2Cr	1.06TCr	1.21TCr	1.21TCr	1.22TCr
Short-Term Borrowings	599.9Cr	499.9Cr	599.9Cr	799.4Cr	798.9Cr
Long-Term Debt	19TCr	21TCr	17TCr	16TCr	16TCr
Pension & Other Post Retirement Benefits	4.58TCr	4.22TCr	4.09TCr	3.55TCr	3.38TCr
Deferred Tax Liability Non-Current	4.1TCr	2.4TCr	479.8Cr	8.56TCr	3.03TCr
Other Non Current Liabilities	1,24700Cr	1,60700Cr	1,46500Cr	1,16100Cr	1,29900Cr
Total Liabilities	16,32400Cr	16,42400Cr	15,78000Cr	15,79700Cr	15,31200Cr
Common Stock, Total	21TCr	21TCr	21TCr	21TCr	21TCr
Additional Paid In Capital	13TCr	6.4TCr	6.4TCr	-	-
Retained Earnings	74TCr	67TCr	50TCr	53TCr	61TCr
Treasury Stock	-5.89TCr	-4.3TCr	-6.84TCr	-2.66TCr	-7.51TCr
Comprehensive Income and Other	53TCr	48TCr	28TCr	69TCr	56TCr
Total Common Equity	1,54600Cr	1,38200Cr	99TCr	1,40400Cr	1,30100Cr
Minority Interest	744.9Cr	759.6Cr	651.1Cr	602Cr	572.1Cr
Total Equity	1,55300Cr	1,39000Cr	99TCr	1,41000Cr	1,30700Cr
Total Liabilities And Equity	17,87700Cr	17,81300Cr	16,77400Cr	17,20700Cr	16,61900Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	59Cr	56Cr	55Cr	53Cr	51Cr
ECS Total Common Shares Outstanding	59Cr	56Cr	55Cr	53Cr	51Cr
Book Value / Share	2.62T	2.46T	1.8T	2.65T	2.54T
Tangible Book Value	1,51300Cr	1,34700Cr	95TCr	1,36100Cr	1,24600Cr
Tangible Book Value Per Share	2.56T	2.4T	1.74T	2.57T	2.43T
Total Debt	21TCr	23TCr	18TCr	18TCr	18TCr
Net Debt	-81TCr	-66TCr	-96TCr	-96TCr	-59TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	4.39TCr	3.93TCr	3.81TCr	2.47TCr	2.37TCr
Minority Interest, Total (Incl. Fin. Div)	744.9Cr	759.6Cr	651.1Cr	602Cr	572.1Cr
Full Time Employees	19.62T	19.64T	20.02T	20.41T	20.9T

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	19TCr	2.29TCr	-10TCr	14TCr	17TCr
Depreciation, Depletion & Amortization	1.98TCr	2.02TCr	2.12TCr	2.1TCr	2.19TCr
Total Depreciation, Depletion & Amortization	1.98TCr	2.02TCr	2.12TCr	2.1TCr	2.19TCr
(Gain) Loss On Sale of Asset - (CF)	263.3Cr	73Cr	-14Cr	-767.9Cr	-175.7Cr
(Gain) Loss on Sale of Investments - (CF)	-1.15TCr	100.3Cr	-6.85TCr	-5.92TCr	-1.82TCr
(Income) Loss On Equity Investments - (CF)	-10TCr	-1.67TCr	22TCr	239.7Cr	120.2Cr
Change in insurance Reserves / Liabilities	48TCr	-26TCr	-45TCr	25TCr	-58TCr
Change in Other Net Operating Assets (Collected)	-444.1Cr	-5.52TCr	13TCr	8.22TCr	14TCr
Other Operating Activities	-7.92TCr	-11TCr	-5.96TCr	-16TCr	-8.77TCr
Cash from Operations	50TCr	-40TCr	-31TCr	26TCr	-36TCr
Capital Expenditure	-1.11TCr	-798.9Cr	-2.23TCr	-1.55TCr	-1.96TCr
Sale of Property, Plant, and Equipment	273.2Cr	94Cr	221.5Cr	1.75TCr	1.46TCr
Investment in Marketable and Equity Securities, Total	-30TCr	32TCr	1,10300Cr	33TCr	-1.42TCr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-2.08TCr	5.52TCr	-5.86TCr	4.44TCr	7.97TCr
Other Investing Activities, Total	7.18TCr	-8.96TCr	-36TCr	-56TCr	3.38TCr
Cash from Investing	-26TCr	28TCr	67TCr	-18TCr	9.43TCr
Short Term Debt Issued, Total	-	-	100Cr	199.5Cr	-
Long-Term Debt Issued, Total	-	2.02TCr	-	-	3.28TCr
Total Debt Issued	-	2.02TCr	100Cr	199.5Cr	3.28TCr
Short Term Debt Repaid, Total	-	-100Cr	-	-	-50L
Long-Term Debt Repaid, Total	-3.2TCr	-	-4.7TCr	-354.1Cr	-3TCr
Total Debt Repaid	-3.2TCr	-100Cr	-4.7TCr	-354.1Cr	-3TCr
Issuance of Common Stock	2.4Cr	3.2Cr	15Cr	37Cr	22Cr
Repurchase of Common Stock	-1.3TCr	-4.55TCr	-2.56TCr	-4TCr	-4.88TCr
Common Dividends Paid	-2.64TCr	-3.07TCr	-3.31TCr	-3.58TCr	-3.94TCr
Common & Preferred Stock Dividends Paid	-2.64TCr	-3.07TCr	-3.31TCr	-3.58TCr	-3.94TCr
Other Financing Activities, Total	-69Cr	-88Cr	-196.8Cr	-217.7Cr	-211.2Cr
Cash from Financing	-7.21TCr	-5.77TCr	-11TCr	-7.92TCr	-8.73TCr
Foreign Exchange Rate Adjustments	73Cr	114.2Cr	-145.5Cr	315.7Cr	236.3Cr
Miscellaneous Cash Flow Adjustments	-	10L	-20L	-10L	166.6Cr
Net Change in Cash	17TCr	-17TCr	25TCr	643.8Cr	-35TCr
Supplemental Items
Cash Interest Paid	156.2Cr	165.4Cr	180.9Cr	143.2Cr	202.3Cr
Cash Income Tax Paid (Refund)	2.68TCr	4.86TCr	-574Cr	4.71TCr	1.35TCr
Net Debt Issued / Repaid	-3.2TCr	1.92TCr	-4.6TCr	-154.6Cr	275Cr
Levered Free Cash Flow	-4.35TCr	-14TCr	27TCr	24TCr	28TCr
Unlevered Free Cash Flow	-4.26TCr	-14TCr	27TCr	24TCr	28TCr
Change In Net Working Capital	22TCr	19TCr	-12TCr	-3TCr	-6.51TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.96	0.22	0.85	1.21	1.28
Return on Total Capital	10.51	2.37	10.51	14.79	14.06
Return On Equity %	12.2	0.98	-11.06	8.32	9.38
Return on Common Equity	12.19	0.97	-11.16	8.26	9.35
Margin Analysis
Gross Profit Margin %	23.35	21.1	25.44	26.75	27.87
SG&A Margin	9.05	13.11	11.22	10.06	10.58
EBITDA Margin %	11.93	4.82	11.44	13.98	14.68
EBITA Margin %	11.09	3.66	10.49	13.14	13.81
EBIT Margin %	11.09	3.66	10.49	13.14	13.81
Income From Continuing Operations Margin %	6.88	0.82	-5.88	4.01	5.08
Net Income Margin %	6.85	0.81	-5.9	3.96	5.04
Net Avail. For Common Margin %	6.85	0.81	-5.9	3.96	5.04
Normalized Net Income Margin	6.36	2.13	-1.12	5.96	6.88
Levered Free Cash Flow Margin	-1.84	-7.81	11.97	9.6	11.26
Unlevered Free Cash Flow Margin	-1.79	-7.75	12.01	9.64	11.32
Asset Turnover
Asset Turnover	0.14	0.1	0.13	0.15	0.15
Fixed Assets Turnover	6.27	4.67	5.93	6.56	6.68
Short Term Liquidity
Current Ratio	13.4	13.67	13.24	12.39	9.82
Quick Ratio	6.82	6	6.72	6.37	4.39
Operating Cash Flow to Current Liabilities	2.84	-2.24	-1.59	1.28	-1.66
Average Days Payable Outstanding	31.07	41.94	36.31	35.65	38.07
Long Term Solvency
Total Debt/Equity	13.52	16.49	18.43	12.88	14.11
Total Debt / Total Capital	11.91	14.16	15.56	11.41	12.36
LT Debt/Equity	12.51	15.37	16.61	11.46	12.56
Long-Term Debt / Total Capital	11.02	13.19	14.03	10.15	11.01
Total Liabilities / Total Assets	91.31	92.2	94.08	91.81	92.14
EBIT / Interest Expense	169.29	37.91	136.4	228.45	144.25
EBITDA / Interest Expense	182.07	49.87	148.7	243.12	153.36
(EBITDA - Capex) / Interest Expense	174.93	45.14	135.76	232.3	145.2
Total Debt / EBITDA	0.74	2.72	0.71	0.52	0.5
Net Debt / EBITDA	-2.87	-7.85	-3.74	-2.74	-1.61
Total Debt / (EBITDA - Capex)	0.77	3	0.78	0.55	0.53
Net Debt / (EBITDA - Capex)	-2.98	-8.67	-4.09	-2.87	-1.7
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.72	-26.26	28.08	11.31	0.68
Gross Profit, 1 Yr. Growth %	3.58	-33.36	54.42	17.07	4.89
EBITDA, 1 Yr. Growth %	7.27	-70.19	204	36.07	5.7
EBITA, 1 Yr. Growth %	7.33	-75.63	266.81	39.39	5.81
EBIT, 1 Yr. Growth %	7.33	-75.63	266.81	39.39	5.81
Earnings From Cont. Operations, 1 Yr. Growth %	143.09	-91.17	-1.01T	-175.92	27.35
Net Income, 1 Yr. Growth %	141.89	-91.26	-1.03T	-174.75	27.98
Normalized Net Income, 1 Yr. Growth %	43.48	-75.31	-167.66	-689.82	16.31
Diluted EPS Before Extra, 1 Yr. Growth %	148.69	-91.02	-1.07T	-177.12	32.01
Net Property, Plant and Equip., 1 Yr. Growth %	-1.34	-0.76	2.62	-1.15	-1.14
Total Assets, 1 Yr. Growth %	8.22	-0.36	-5.84	2.58	-3.42
Common Equity, 1 Yr. Growth %	38.4	-10.6	-28.56	42.22	-7.32
Tangible Book Value, 1 Yr. Growth %	39.29	-10.97	-29.25	42.8	-8.41
Cash From Operations, 1 Yr. Growth %	-15.33	-179.3	-22.49	-185.41	-236.96
Capital Expenditures, 1 Yr. Growth %	-53.51	-27.91	179.02	-30.43	26.38
Levered Free Cash Flow, 1 Yr. Growth %	-43.76	213.66	-296.25	-10.68	18.06
Unlevered Free Cash Flow, 1 Yr. Growth %	-44.55	218.33	-298.58	-10.71	18.24
Dividend Per Share, 1 Yr. Growth %	4.55	21.74	10.71	12.9	14.29
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.7	-10.46	-2.81	19.4	5.86
Gross Profit, 2 Yr. CAGR %	6.94	-16.92	1.45	34.45	10.81
EBITDA, 2 Yr. CAGR %	11.79	-43.46	-4.81	103.39	19.93
EBITA, 2 Yr. CAGR %	12.39	-48.86	-5.45	126.12	21.44
EBIT, 2 Yr. CAGR %	12.39	-48.86	-5.45	126.12	21.44
Earnings From Cont. Operations, 2 Yr. CAGR %	49.68	-53.66	-10.14	163.42	-1.67
Net Income, 2 Yr. CAGR %	49.29	-54.03	-9.77	163.93	-2.2
Normalized Net Income, 2 Yr. CAGR %	31.34	-40.48	-59.13	99.77	161.92
Diluted EPS Before Extra, 2 Yr. CAGR %	52.82	-52.74	-6.47	174.09	0.9
Net Property, Plant and Equip., 2 Yr. CAGR %	0.82	-1.05	0.92	0.72	-1.15
Total Assets, 2 Yr. CAGR %	6.39	3.84	-3.14	-1.72	-0.46
Common Equity, 2 Yr. CAGR %	15.72	11.24	-20.08	0.79	14.8
Tangible Book Value, 2 Yr. CAGR %	15.92	11.36	-20.64	0.51	14.36
Cash From Operations, 2 Yr. CAGR %	-6.86	-18.06	-21.6	-18.63	8.16
Capital Expenditures, 2 Yr. CAGR %	-25.4	-42.11	41.83	39.32	-6.24
Levered Free Cash Flow, 2 Yr. CAGR %	11.73	32.82	148.11	32.4	2.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.59	32.85	151.42	33.16	2.75
Dividend Per Share, 2 Yr. CAGR %	4.65	12.82	16.1	11.8	13.59
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.44	-6.26	0.89	1.68	12.8
Gross Profit, 3 Yr. CAGR %	5.41	-8.66	2.15	6.41	23.77
EBITDA, 3 Yr. CAGR %	9.24	-28.05	-0.94	7.23	63.52
EBITA, 3 Yr. CAGR %	9.34	-32.48	-1.37	7.61	75.55
EBIT, 3 Yr. CAGR %	9.34	-32.48	-1.37	7.61	75.55
Earnings From Cont. Operations, 3 Yr. CAGR %	28.12	-41.72	25.2	-15.05	106.74
Net Income, 3 Yr. CAGR %	27.9	-42.04	25.35	-15.26	107.35
Normalized Net Income, 3 Yr. CAGR %	16.92	-24.76	-37.88	-0.49	66.81
Diluted EPS Before Extra, 3 Yr. CAGR %	30.59	-40.59	29.58	-12.29	114.85
Net Property, Plant and Equip., 3 Yr. CAGR %	1.11	0.29	0.16	0.22	0.09
Total Assets, 3 Yr. CAGR %	5.41	4.09	0.51	-1.27	-2.29
Common Equity, 3 Yr. CAGR %	10.4	6.19	-4.03	-3.16	-1.99
Tangible Book Value, 3 Yr. CAGR %	10.48	6.16	-4.27	-3.47	-2.56
Cash From Operations, 3 Yr. CAGR %	10.58	-11.72	-19.56	-19.33	-3.21
Capital Expenditures, 3 Yr. CAGR %	-40.89	-26.25	-2.21	11.85	34.87
Levered Free Cash Flow, 3 Yr. CAGR %	146.63	57.62	51.28	76.5	27.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	134.52	56.37	51.9	78.05	27.99
Dividend Per Share, 3 Yr. CAGR %	7.05	10.06	12.11	15.02	12.62
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.36	-2.24	3.21	3.27	2.85
Gross Profit, 5 Yr. CAGR %	2.88	-6.41	3.8	6.62	5.53
EBITDA, 5 Yr. CAGR %	6.04	-19.94	3.39	9.03	6.93
EBITA, 5 Yr. CAGR %	6.09	-23.21	3.16	9.49	7.19
EBIT, 5 Yr. CAGR %	6.09	-23.21	3.16	9.49	7.19
Earnings From Cont. Operations, 5 Yr. CAGR %	17.55	-28.16	11.17	6.55	13.67
Net Income, 5 Yr. CAGR %	17.48	-28.37	11.24	6.29	13.5
Normalized Net Income, 5 Yr. CAGR %	6.86	-20.77	-23.21	11.19	10.46
Diluted EPS Before Extra, 5 Yr. CAGR %	19.93	-26.76	14.27	9.52	17.24
Net Property, Plant and Equip., 5 Yr. CAGR %	3.55	3.1	1.03	0.46	-0.37
Total Assets, 5 Yr. CAGR %	4.03	3.65	1.91	1.73	0.12
Common Equity, 5 Yr. CAGR %	4.99	4.78	-2.98	3.99	3.1
Tangible Book Value, 5 Yr. CAGR %	4.96	4.69	-3.21	3.86	2.79
Cash From Operations, 5 Yr. CAGR %	10.09	2.92	-3.63	-14.56	-9.45
Capital Expenditures, 5 Yr. CAGR %	-16.09	-14.4	-16.11	-4.88	-3.84
Levered Free Cash Flow, 5 Yr. CAGR %	-42.4	-7.99	147.22	47	29.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	-42.65	-8.17	141.14	46.63	29.91
Dividend Per Share, 5 Yr. CAGR %	8.92	11.5	10.58	10.76	12.7